Form D · Biotechnology
Second Heart Assist, Inc.
Salt Lake City, UT · CIK 0001723176
Offering snapshot reported Feb 7, 2025 · SEC filing
- Reported sold
- $18.3M Indefinite offering
- Investors reported
- 284 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Dec 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2025 | Initial | $18,303,838 | No comparison | 284 | SEC filing |
| Feb 7, 2025 | Initial | $16,978,238 | No comparison | 277 | SEC filing |
| Feb 7, 2025 | Initial | $17,803,838 | No comparison | 283 | SEC filing |
| Nov 18, 2022 | Initial | $602,367 | No comparison | 7 | SEC filing |
| Nov 18, 2022 | Initial | $2,020,461 | No comparison | 61 | SEC filing |
| Nov 18, 2022 | Initial | $4,334,867 | No comparison | 106 | SEC filing |
| Nov 16, 2022 | Initial | $14,673,782 | No comparison | 258 | SEC filing |
| Apr 22, 2021 | Amendment | $8,621,204 | $4,510,336vs Oct 3, 2019 | 211 | SEC filing |
| Oct 3, 2019 | Initial | $4,110,868 | No comparison | 76 | SEC filing |
| Jan 26, 2018 | Initial | $1,000,000 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537621
Source: Form D, filed Feb 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ghannam Al Dossari | Director |
| Brett Burton | Director |
| Mark Cunningham | Director |
| Jefferey Donofrio | Director, Executive |
| Jeffrey Donofrio | Director |
| Ken Evans | Director |
| Patrick Griffith | Director |
| Stuart Kozlick | Executive |
| Howard Leonhardt | Director |
| Mark Libratore | Director |
| Les Miller | Director |
| Dinesh Patel | Director |
| Alex Richardson | Director |
| Clay Taylor | Director |
| Robyn Thornburgh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
370 S 300 E.
Salt Lake City, UT, 84111
Salt Lake City, UT, 84111